Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.08B |
| 2 |
Deere & Co
DE
|
+$875M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$555M |
| 4 |
Microsoft
MSFT
|
+$498M |
| 5 |
Netflix
NFLX
|
+$454M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.02B |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$906M |
| 3 |
Air Products & Chemicals
APD
|
+$725M |
| 4 |
SWN
Southwestern Energy Company
SWN
|
+$585M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$541M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 30.16% |
| 2 | Healthcare | 12.22% |
| 3 | Consumer Discretionary | 11.29% |
| 4 | Energy | 10.3% |
| 5 | Technology | 10.18% |
Similar funds
Andreas Halvorsen's Q4 2016 Portfolio in Review
As of Q4 2016, Andreas Halvorsen held 85 positions worth $22B, down 5.1% from $23.2B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Andreas Halvorsen withdrew a net $969M in Q4 2016, closing 23 positions and reducing 18 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $906M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Andreas Halvorsen opened a new position in DuPont de Nemours worth $1.12B.
- Andreas Halvorsen's largest Q4 2016 buy was DuPont de Nemours: 7,760,161 shares worth $1.12B.
- Andreas Halvorsen added most to Walgreens Boots Alliance in Q4 2016, an estimated $555M increase.
- Andreas Halvorsen's biggest Q4 2016 reduction was Amazon, cutting an estimated $1.02B.
- Andreas Halvorsen fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $906M.
- Andreas Halvorsen's ten largest holdings make up 54% of its $22B portfolio in Q4 2016.
- Andreas Halvorsen opened 23 new positions and closed 23 in Q4 2016.
- Andreas Halvorsen's portfolio value fell 5.1% quarter-over-quarter to $22B.
Based on Viking Global Investors's 13F filing for Q4 2016, filed 14 Feb 2017.